NEW YORK (GenomeWeb) – PathoQuest announced today it has entered a collaboration with Memorial Sloan Kettering Cancer Center (MSK) to establish the company's iDtect blood test within MSK's microbiology lab.

In addition, PathoQuest will compare the iDtect blood test with standard testing methods used to identify microbes responsible for infections in patients with febrile neutropenia.

Febrile neutropenia is the development of fever in a patient with neutropenia, an abnormally low number of white blood cells in the bloodstream.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.